NCT00324259View on ClinicalTrials.gov

Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

March 31, 2011

Study Completion Date

August 31, 2014

Conditions
Breast Neoplasms
Interventions
DRUG

Estradiol

Trial Locations (7)

10021

Memorial Sloan-Kettering Cancer Center, New York

27599

University of North Carolina Breast Clinic, Chapel Hill

27710

Duke University Medical Center, Durham

44106

Case Western University, Cleveland

44195

Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University, Cleveland

60637

University of Chicago, Chicago

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT00324259 - Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter